W. Jeffrey Baker, M.D., Hematologist/Medical Oncologist
Undergraduate: Dartmouth College -1980 BA
Medical School: Tufts University School of Medicine -1984 MD
Residency: Walter Reed Army Medical Center 1984-1987 Internal Medicine
Fellowship: Walter Reed Army Medical Center 1987-1990 Hematology/Oncology
Military service: 1984-1994; Rank: Major (04)
Site director for UCONN Hematology Oncology Fellowship Program
Medical Director of Clinical Cancer Research at Hartford Hospital
Member of the Hartford Hospital Cancer Committee
Member of the Windham Hospital Cancer Committee (Cancer Liaison Physician)
Assistant Clinical Professor at the University of Connecticut School of Medicine
Windham Hospital Physician of the Year award winner, 2012
Meritorious Service Award (US Army, 1994)
Member of the American Society of Clinical Oncology (ASCO)
Member of the American Society of Hematology (ASH)
AREAS OF INTEREST
- Baker, W.J., Royer, G.L., & Weiss, R.B. (1991). Cytarabine and neurologic toxicity. Journal of Clinical Oncology, 9, 679-693.
- Baker, W.J., Hargis, J.B., Danesi, R., & LaRocca, R.V. (1991). The effect of hGM-CSF on the proliferation of osteogenic sarcoma cells. American Journal of Hematology, 37, 84-87.
- Baker, W.J., Maenpaa, J.U., Wurz, G.T., Koester, S.K., Seymour, R.C., Emshoff, V.D., Wiebe, V.J., & DeGregorio, M.W. (1993). Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells. Oncology Research, 5, 2-7-212.
- Baker, W.J., Vukelja, S.J., Burrell, L.M., Lee, N., & Perry, J.J. (1998). High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results. Bone Marrow Transplantation, 21, 775-558.
Hartford, Avon, Windham